Joseph P Lyssikatos
CHIEF SCIENTIFIC OFFICER · 3 filings · Latest: Feb 12, 2026
Enliven Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ELVN | Lyssikatos Joseph P | — | Oct 9, 2024 | Proposed Sale | $28.01 | 12,000 | $336.1K | — |
← Previous
Page 2 of 2